Improving clinical trial enrollment in minority racial and ethnic patients with gynecologic malignancy

Olivia D Lara1, Kathryn Allen2, Amin Yakubov2

  • 1Division of Gynecologic Oncology, Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC, USA.

Gynecologic Oncology Reports
|September 19, 2024
PubMed
Abstract

Insights

Implementing pre-screening and fast-track referrals significantly increased minority participation in gynecologic cancer clinical trials. These strategies are crucial for improving diversity in cancer research.

Area of Science:

  • Oncology
  • Clinical Trials
  • Health Equity

Background:

  • Racial and ethnic minorities are underrepresented in clinical trials.
  • This disparity can lead to therapeutic interventions not being representative of the general population.
  • Ensuring diverse trial participation is critical for equitable healthcare outcomes.

Purpose of the Study:

  • To evaluate the effectiveness of implementation strategies in increasing the enrollment of underrepresented patients in gynecologic cancer clinical trials.
  • To assess the impact of pre-screening and fast-track referral on minority participation.

Main Methods:

  • An interrupted time series analysis was conducted from January 2021 to May 2022.
  • Implementation strategies included pre-screening and fast-track referral.
  • Descriptive analysis compared patient screening and accrual rates before and after the intervention.

Main Results:

  • Clinical trial screening increased 2.5-fold overall and 5-fold for minority patients.
  • Enrollment in gynecologic cancer clinical trials increased 3.5-fold post-intervention.
  • Minority enrollment increased significantly, with all 7 post-intervention enrollees being from underrepresented racial and ethnic groups.

Conclusions:

  • A combination of pre-screening and fast-track referral significantly improved minority screening and enrollment in gynecologic cancer clinical trials.
  • Structured strategies are urgently needed to overcome barriers to patient accrual in academic hospitals.
  • These findings highlight the importance of targeted interventions for enhancing diversity in clinical research.